Moderna’s new ‘bivalent’ coronavirus vaccine gives eight-fold boost in antibodies and fights both original Covid and Omicron

Moderna’s new ‘bivalent’ coronavirus vaccine gives eight-fold boost in antibodies and fights both original Covid and Omicron

City A.M.

Published

Pharma giant Moderna said this afternoon that its new bivalent vaccine targets both the original Covid strain and the Omicron variant. The US firm said early clinical trials on 437 people had shown the jab led to an eight-fold jump in the levels of Omicron-specific “neutralising” antibodies compared to people who had not received a [...]

Full Article